Liver cell-targeted delivery of therapeutic molecules

Jeong Hun Kang, Riki Toita, Masaharu Murata

    Research output: Contribution to journalReview article

    18 Citations (Scopus)

    Abstract

    The liver is the largest internal organ in mammals and is involved in metabolism, detoxification, synthesis of proteins and lipids, secretion of cytokines and growth factors and immune/inflammatory responses. Hepatitis, alcoholic or non-alcoholic liver disease, hepatocellular carcinoma, hepatic veno-occlusive disease, and liver fibrosis and cirrhosis are the most common liver diseases. Safe and efficient delivery of therapeutic molecules (drugs, genes or proteins) into the liver is very important to increase the clinical efficacy of these molecules and to reduce their side effects in other organs. Several liver cell-targeted delivery systems have been developed and tested in vivo or ex vivo/in vitro. In this review, we discuss the literature concerning liver cell-targeted delivery systems, with a particular emphasis on the results of in vivo studies.

    Original languageEnglish
    Pages (from-to)132-143
    Number of pages12
    JournalCritical Reviews in Biotechnology
    Volume36
    Issue number1
    DOIs
    Publication statusPublished - Jan 2 2016

    Fingerprint

    Liver
    Liver Cirrhosis
    Liver Diseases
    Hepatic Veno-Occlusive Disease
    Alcoholic Hepatitis
    Therapeutics
    Mammals
    Hepatocellular Carcinoma
    Intercellular Signaling Peptides and Proteins
    Proteins
    Cytokines
    Lipids
    Pharmaceutical Preparations
    In Vitro Techniques

    All Science Journal Classification (ASJC) codes

    • Biotechnology
    • Applied Microbiology and Biotechnology

    Cite this

    Liver cell-targeted delivery of therapeutic molecules. / Kang, Jeong Hun; Toita, Riki; Murata, Masaharu.

    In: Critical Reviews in Biotechnology, Vol. 36, No. 1, 02.01.2016, p. 132-143.

    Research output: Contribution to journalReview article

    Kang, Jeong Hun ; Toita, Riki ; Murata, Masaharu. / Liver cell-targeted delivery of therapeutic molecules. In: Critical Reviews in Biotechnology. 2016 ; Vol. 36, No. 1. pp. 132-143.
    @article{9a3085e59d8c470a91c04005b2fe7008,
    title = "Liver cell-targeted delivery of therapeutic molecules",
    abstract = "The liver is the largest internal organ in mammals and is involved in metabolism, detoxification, synthesis of proteins and lipids, secretion of cytokines and growth factors and immune/inflammatory responses. Hepatitis, alcoholic or non-alcoholic liver disease, hepatocellular carcinoma, hepatic veno-occlusive disease, and liver fibrosis and cirrhosis are the most common liver diseases. Safe and efficient delivery of therapeutic molecules (drugs, genes or proteins) into the liver is very important to increase the clinical efficacy of these molecules and to reduce their side effects in other organs. Several liver cell-targeted delivery systems have been developed and tested in vivo or ex vivo/in vitro. In this review, we discuss the literature concerning liver cell-targeted delivery systems, with a particular emphasis on the results of in vivo studies.",
    author = "Kang, {Jeong Hun} and Riki Toita and Masaharu Murata",
    year = "2016",
    month = "1",
    day = "2",
    doi = "10.3109/07388551.2014.930017",
    language = "English",
    volume = "36",
    pages = "132--143",
    journal = "Critical Reviews in Biotechnology",
    issn = "0738-8551",
    publisher = "Informa Healthcare",
    number = "1",

    }

    TY - JOUR

    T1 - Liver cell-targeted delivery of therapeutic molecules

    AU - Kang, Jeong Hun

    AU - Toita, Riki

    AU - Murata, Masaharu

    PY - 2016/1/2

    Y1 - 2016/1/2

    N2 - The liver is the largest internal organ in mammals and is involved in metabolism, detoxification, synthesis of proteins and lipids, secretion of cytokines and growth factors and immune/inflammatory responses. Hepatitis, alcoholic or non-alcoholic liver disease, hepatocellular carcinoma, hepatic veno-occlusive disease, and liver fibrosis and cirrhosis are the most common liver diseases. Safe and efficient delivery of therapeutic molecules (drugs, genes or proteins) into the liver is very important to increase the clinical efficacy of these molecules and to reduce their side effects in other organs. Several liver cell-targeted delivery systems have been developed and tested in vivo or ex vivo/in vitro. In this review, we discuss the literature concerning liver cell-targeted delivery systems, with a particular emphasis on the results of in vivo studies.

    AB - The liver is the largest internal organ in mammals and is involved in metabolism, detoxification, synthesis of proteins and lipids, secretion of cytokines and growth factors and immune/inflammatory responses. Hepatitis, alcoholic or non-alcoholic liver disease, hepatocellular carcinoma, hepatic veno-occlusive disease, and liver fibrosis and cirrhosis are the most common liver diseases. Safe and efficient delivery of therapeutic molecules (drugs, genes or proteins) into the liver is very important to increase the clinical efficacy of these molecules and to reduce their side effects in other organs. Several liver cell-targeted delivery systems have been developed and tested in vivo or ex vivo/in vitro. In this review, we discuss the literature concerning liver cell-targeted delivery systems, with a particular emphasis on the results of in vivo studies.

    UR - http://www.scopus.com/inward/record.url?scp=84949315979&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84949315979&partnerID=8YFLogxK

    U2 - 10.3109/07388551.2014.930017

    DO - 10.3109/07388551.2014.930017

    M3 - Review article

    C2 - 25025274

    AN - SCOPUS:84949315979

    VL - 36

    SP - 132

    EP - 143

    JO - Critical Reviews in Biotechnology

    JF - Critical Reviews in Biotechnology

    SN - 0738-8551

    IS - 1

    ER -